Compound ID | 2899

Update compound information

Cresomycin

Class: Protein synthesis inhibitor

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Active against susceptible and multidrug-resistant Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus haemolyticus, Streptococcus pneumoniae, Streptococcus pyogenes, multidrug-resistant Enterococcus faecalis, multidrug- and vancomycin-resistant Enterococcus faecium, Clostridioides difficile, Neisseria gonorrhoeae, susceptible and multidrug-resistant Escherichia coli, carbapenem-resistant: Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa; binds to ribosomes
Description: Synthetic compound; 100% survival of mice infected with cfr-expressing Staphylococcus aureus after subcutaneous treatment with cresomycin vs 10% survival without treatment
Year first mentioned: 2024
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 498.68
Iso. SMILES: C[C@@H]1/C=C\CCS[C@@H]2[C@@H]([C@H]([C@H]([C@@H]([C@@H]1NC(=O)[C@@H]3[C@H]4[C@@H](C[C@@H](CCO4)CC(C)C)CN3)O2)O)O)O
InChI Key: GMONVEGLHZWYNO-JBYNEVPESA-N
Can. SMILES: CC(C)C[C@@H]1CCO[C@@H]2[C@@H](C1)CN[C@@H]2C(=O)N[C@@H]3[C@H](C)/C=C\CCS[C@@H]4[C@@H]([C@H]([C@H]([C@@H]3O4)O)O)O
InChI: InChI=1S/C25H42N2O6S/c1-13(2)10-15-7-8-32-22-16(11-15)12-26-18(22)24(31)27-17-14(3)6-4-5-9-34-25-21(30)19(28)20(29)23(17)33-25/h4,6,13-23,25-26,28-30H,5,7-12H2,1-3H3,(H,27,31)/b6-4-/t14-,15+,16+,17-,18+,19+,20-,21-,22-,23-,25-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/169247206
Guide to Pharmacology: cresomycin
Citation: https://www.science.org/doi/10.1126/science.adk8013

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.